Description

Methyltestosterone 25 mg by Swiss Healthcare is a pharmaceutical-grade oral androgen, historically utilized in medical settings to treat male hypogonadism, delayed puberty, and hormonal imbalances. In research environments, it is studied for its effects on androgen receptor activation, muscle mass retention, libido modulation, and performance support.

As a 17-alpha alkylated testosterone derivative, Methyltestosterone is orally bioavailable and delivers potent androgenic activity with moderate anabolic effects. Its structure makes it useful in short-term studies involving androgen response, though liver values must be closely monitored due to its hepatotoxic nature.

Swiss Healthcare ensures pharmaceutical-grade manufacturing standards. Each bottle includes 60 tablets, dosed at 25 mg per tablet, for consistent and controlled administration in research-only protocols.

Product Details

• Active Ingredient: Methyltestosterone

• Concentration per Tablet: 25 mg

• Form: Oral tablets

• Package Size: 60 tablets per bottle

Pharmacokinetics

Methyltestosterone has a short half-life of approximately 3–4 hours, with rapid onset and peak serum levels occurring within 1–2 hours of administration. It is highly androgenic, with strong effects on secondary male characteristics, strength output, and nitrogen retention in tissue studies.

Usage Recommendations

• Typical Research Dosage (historical reference): 10–50 mg per day

• Current Use: Intended strictly for research and laboratory purposes

• Administration: Oral

Disclaimer

This product is for research and laboratory use only. It is not approved for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with liver, cardiovascular, or prostate conditions. Always follow local laws and lab safety protocols.